A Multicenter, Randomized, Double-Blind, Parallel-Group Study Comparing the Efficacy and Safety of Clonidine Topical Gel, 0.1% With Placebo in the Management of Pain Associated With Painful Diabetic Neuropathy
Phase of Trial: Phase II
Latest Information Update: 12 Nov 2016
At a glance
- Drugs Clonidine (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- Sponsors Arcion Therapeutics
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
- 14 Jun 2011 Results from this study will be presented at the American Diabetes Association's 71st Scientific Sessions and the Peripheral Nerve Society 2011 Biennial Meeting, both of which will be held in June 2011.
- 21 Jul 2010 Top-line results reported in an Arcion Therapeutics media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History